国际肝胆胰疾病杂志（英文版）2018，Vol.17Issue(4)：301-309,9.
Chimeric antigen receptor-engineered T-cell therapy for liver cancer
Chimeric antigen receptor-engineered T-cell therapy for liver cancer
Yang Chen 1Chang-Yong E 2Zhi-Wen Gong 1Shui Liu 1Zhen-Xiao Wang 1Yong-Sheng Yang 1Xue-Wen Zhang1
作者信息
- 1. Department of Hepatobiliary and Pancreas Surgery, the Second Hospital of Jilin University, Changchun 130041, China
- 2. Department of Hepatobiliary and Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun 130021, China
- 折叠
摘要
关键词
Liver cancer/Chimeric antigen receptor-engineered T-cell therapy/Immunotherapy/Tumor-associated antigenKey words
Liver cancer/Chimeric antigen receptor-engineered T-cell therapy/Immunotherapy/Tumor-associated antigen引用本文复制引用
Yang Chen,Chang-Yong E,Zhi-Wen Gong,Shui Liu,Zhen-Xiao Wang,Yong-Sheng Yang,Xue-Wen Zhang..Chimeric antigen receptor-engineered T-cell therapy for liver cancer[J].国际肝胆胰疾病杂志（英文版）,2018,17(4):301-309,9.
